Application of recombinant protein technologies in the development of innovative medical devices for BV treatment (Q3798321)

From EU Knowledge Graph
Revision as of 10:33, 28 November 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in fr: translated_label)
Jump to navigation Jump to search
Project Q3798321 in Lithuania
Language Label Description Also known as
English
Application of recombinant protein technologies in the development of innovative medical devices for BV treatment
Project Q3798321 in Lithuania

    Statements

    0 references
    1,110,770.11 Euro
    0 references
    Uždaroji akcinė bendrovė "Profarma"
    0 references
    0 references

    Identifiers

    J05-LVPA-K-04-0085
    0 references